The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) (NCT06321575)
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy
🩺 Plain-English Summary (8th-Grade Level)
The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.
Who can join: Review the eligibility criteria below.
Location: HonorHealth Scottsdale Osborn Medical Center — Scottsdale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (20 Sites)
- HonorHealth Scottsdale Osborn Medical Center — Scottsdale, Arizona
- Pulse Cardiovascular Institute — Scottsdale, Arizona
- Merced Vascular — Merced, California
- Palm Vascular Center — Fort Lauderdale, Florida
- First Coast Cardiovascular Institute — Jacksonville, Florida
- Radiology and Imaging Specialists of Lakeland — Lakeland, Florida
- Amavita Research Services — Miami, Florida
- Cardiovascular Consultants of South Georgia — Thomasville, Georgia
- Pacific Vascular Institute — ‘Aiea, Hawaii
- Baton Rouge General Hospital — Baton Rouge, Louisiana
- Cardiovascular Institute of the South - Houma — Houma, Louisiana
- Cardiovascular Institute of the South - Lafayette — Lafayette, Louisiana
- Vascular Breakthroughs — Plymouth, Massachusetts
- Advanced Heart and Vascular Institute — Flemington, New Jersey
- Spartanburg Regional Medical Center — Spartanburg, South Carolina
- Tennessee Center for Clinical Trials — Tullahoma, Tennessee
- Nextstage Clinical Research - Beaumont — Beaumont, Texas
- Hope Vascular & Podiatry — Houston, Texas
- Nextstage Clinical Research - Waco — Waco, Texas
- Bellin Health — Green Bay, Wisconsin
📞 Contact the Study Coordinator
Phone: (858) 945-0007
Email: Gene.Reu@nipromed.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Arterial Disease
- SELUTION4SFA Trial — Little Rock, Arkansas
- SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — New Haven, Connecticut
- A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) — Birmingham, Alabama
- Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy — Indianapolis, Indiana
- FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease — Chicago, Illinois
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology — Omaha, Nebraska
Explore by condition: All Peripheral Arterial Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.